Randomization and allocation concealment: a practical guide for researchers

Begg, 1996, Improving the quality of reporting of randomized controlled trials. The CONSORT statement, JAMA, 276, 637, 10.1001/jama.276.8.637

1979, vol. 1

Schulz, 1995, Subverting randomization in controlled trials, JAMA, 274, 1456, 10.1001/jama.274.18.1456

Doig, 2005, A review of the true methodological quality of nutritional support trials conducted in the critically ill: time for improvement, Anesth Analg, 100, 527, 10.1213/01.ANE.0000141676.12552.D0

Altman, 1999, Statistics notes. Treatment allocation in controlled trials: why randomise?, BMJ, 318, 1209, 10.1136/bmj.318.7192.1209

Altman, 2001, The revised CONSORT statement for reporting randomized trials: explanation and elaboration, Ann Intern Med, 134, 663, 10.7326/0003-4819-134-8-200104170-00012

Juni, 2001, Systematic reviews in health care: assessing the quality of controlled clinical trials, BMJ, 323, 42, 10.1136/bmj.323.7303.42

Forder, 2005, Allocation concealment and blinding: when ignorance is bliss, Med J Aust, 182, 87, 10.5694/j.1326-5377.2005.tb06584.x

Piper, 1996, Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis, Crit Care Med, 24, 2059, 10.1097/00003246-199612000-00021

Schulz, 2002, Allocation concealment in randomised trials: defending against deciphering, Lancet, 359, 614, 10.1016/S0140-6736(02)07750-4

Altman, 2001, Statistics notes: concealing treatment allocation in randomised trials, BMJ, 323, 446, 10.1136/bmj.323.7310.446

Schulz, 2002, Unequal group sizes in randomised trials: guarding against guessing, Lancet, 359, 966, 10.1016/S0140-6736(02)08029-7